Prosecution Insights
Last updated: August 17, 2026

Examiner: LI, BAO Q

Tech Center 1600 • Art Units: 1648 1654 1671 1675

This examiner grants 76% of resolved cases

Performance Statistics

75.5%
Allow Rate
+15.5% vs TC avg
931
Total Applications
+26.4%
Interview Lift
1035
Avg Prosecution Days
Based on 905 resolved cases, 2023–2026

Rejection Statute Breakdown

3.5%
§101 Eligibility
26.8%
§102 Novelty
22.2%
§103 Obviousness
26.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18029467 METHODS FOR DETECTING ANTIBODIES Final Rejection The Regents of the University of California
18252800 MODIFIED SECRETED HEPATITIS C VIRUS (HCV) E1E2 GLYCOPROTEINS AND METHODS OF USE THEREOF Non-Final OA THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
18050806 THERAPEUTIC AND PREVENTATIVE CANCER VACCINES Non-Final OA Arizona Board of Regents on Behalf of Arizona State University
17747358 MULTIGENIC MVA-SARS-COV-2 VACCINE Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18684496 FMDV VIRUS-LIKE PARTICLE WITH DOUBLE STABILIZING MUTATION Non-Final OA THE PIRBRIGHT INSTITUTE

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month